Retinal Implants Market Size, Share & Trends Analysis Report By Type (Retina Implant Alpha AMS, Implantable Miniature), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030

Retinal Implants Market Growth & Trends

The global retinal implants market size is expected to reach USD 84.1 million in 2030 and is projected to grow at a CAGR of 8.3% from 2025 to 2030. The market players are rapidly developing technological advancements to the devices to cater to the unmet patient needs, Owing to the lack of treatment options available for permanently blind individuals. The potential for restoring vision, the growing senior population, and the increasing prevalence of target illnesses drive up demand for retinal implants. The market is expanding owing to the rising frequency of retinal disorders worldwide.

Increasing research developments and advancements to develop novel solutions for the growing prevalence of rare genetic conditions causing vision loss and advancing clinical trials are driving the market. According to the article published in MIT Technology, an estimated 1.5 million people worldwide, including around 100,000 people in the U.S., have retinitis pigmentosa. In January 2018, Pixium Vision received the U.S. FDA approval to initiate clinical trials for PRIMA, a sub-retinal implant. The implant was approved for practice in patients with atrophic dry Age-related Macular Degeneration (AMD).

According to the CDC, age-related diseases such as macular degeneration, cataracts, and diabetic retinopathy are the leading causes of reduced vision and blindness in the U.S. Amblyopia and strabismus are two frequent eye conditions. Legally blind or partially sighted, 4.2 million Americans aged 40 and older fall into these categories. According to the National Eye Institute, over 150 million Americans' eyesight could be improved by appropriate refractive surgery.

Retinal Implants Market Report Highlights

• Based on the device type, the market is segmented into retina implant alpha AMS, implantable miniature telescope, Argus II, and others. The Argus II segment accounted for the largest revenue share of around 34.7% in 2024
• Based on end use, the market is segmented into hospitals, outpatient facilities, and research & manufacturing
• Mergers and acquisitions (M&A) in the retinal implants industry have been growing as companies seek to expand their technological capabilities, product portfolios, and market presence.
• The retinal implants industry is characterized by rapid technological advancements and increasing demand due to rising cases of retinal diseases like retinitis pigmentosa and diabetic retinopathy
• North American retinal implants market held a dominant position, capturing 37.5% of the global revenue share in 2024

Please note The report will be delivered in 2-3 business days upon order notification.